Delivery Order SPE2DB24D2216-SPE2DB25FGNMF

Award Date 4/28/25
Potential Completion Date 4/29/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,404.98, is for the delivery of BELBUCA 600 MCG FILM 60S, a prescription medication. The contract has an ultimate completion date of August 1, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Belbuca 600 mcg film in 60-count packages, with a ceiling value of $1,782.68 and a completion date of April 7, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not designated as a Set-Aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,488.72 and an ultimate completion date of December 12, 2024. The award is for the delivery of BELBUCA 750 MCG FILM 60S, a pharmaceutical product. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, with ID SPE2DB22D2206|SPE2DB25FGT60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply 4,568,062,264 units of the medication Belbuca 300 MCG film in 60-count packages. The contract is a delivery order with a firm fixed price of $1,416.79 and a completion date of April 29, 2025. The contract is not set-aside and was openly competed. AmerisourceBergen Drug Corp is the prime contractor, and the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,268.98 firm fixed-price contract is for the delivery of BELBUCA 600 MCG FILM 60S, a pharmaceutical product, with a completion date of December 3, 2024. The award is not associated with a set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,023.86 firm fixed-price contract is for the supply of BELBUCA 600 MCG FILM 60S, a prescription medication. The order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BELBUCA 900 MCG FILM 60S, a pharmaceutical product, with a ceiling value of $2,433.63 and a completion date of February 27, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BELBUCA 75 MCG FILM 60S, a pharmaceutical product. The contract has a ceiling value of $1,106.54 and a completion date of March 6, 2025. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,453.96 firm fixed-price delivery order is for the supply of BELBUCA 300 MCG FILM 60S, a prescription medication. The award has an ultimate completion date of February 13, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BELBUCA 750 MCG FILM 60S, a pharmaceutical product, and has a ceiling value of $1,460.16. The contract is a firm fixed-price, delivery order contract with a period of performance that runs through January 8, 2025. The contract does not have a set-aside designation, indicating it was competitively awarded....
  • SPE2DB24D2216
    Indefinite Delivery Contract
  • SPE2DB24D2216-SPE2DB25FGNMF
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,435.28, is for the delivery of 4,568,060,763 units of the prescription medication Belbuca 300 MCG Film 60S. The contract has an ultimate completion date of April 29, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for military and government healthcare programs through December 2026.

Generated 7/28/25, 11:06 AM